fernbrook bio limited Company Information
Company Number
06595831
Next Accounts
Sep 2025
Industry
Treatment and disposal of non-hazardous waste
Shareholders
generate uk ad i limited
Group Structure
View All
Contact
Registered Address
fernbrook bio rothwell road, kettering, NN16 8XF
Website
www.fernbrookbio.co.ukfernbrook bio limited Estimated Valuation
Pomanda estimates the enterprise value of FERNBROOK BIO LIMITED at £1.3m based on a Turnover of £2.3m and 0.54x industry multiple (adjusted for size and gross margin).
fernbrook bio limited Estimated Valuation
Pomanda estimates the enterprise value of FERNBROOK BIO LIMITED at £3.4m based on an EBITDA of £952k and a 3.59x industry multiple (adjusted for size and gross margin).
fernbrook bio limited Estimated Valuation
Pomanda estimates the enterprise value of FERNBROOK BIO LIMITED at £10.2m based on Net Assets of £3.9m and 2.64x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Fernbrook Bio Limited Overview
Fernbrook Bio Limited is a live company located in kettering, NN16 8XF with a Companies House number of 06595831. It operates in the treatment and disposal of non-hazardous waste sector, SIC Code 38210. Founded in May 2008, it's largest shareholder is generate uk ad i limited with a 100% stake. Fernbrook Bio Limited is a established, small sized company, Pomanda has estimated its turnover at £2.3m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Fernbrook Bio Limited Health Check
Pomanda's financial health check has awarded Fernbrook Bio Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 3 areas for improvement. Company Health Check FAQs
5 Strong
4 Regular
3 Weak
Size
annual sales of £2.3m, make it smaller than the average company (£14.7m)
- Fernbrook Bio Limited
£14.7m - Industry AVG
Growth
3 year (CAGR) sales growth of 10%, show it is growing at a faster rate (7.5%)
- Fernbrook Bio Limited
7.5% - Industry AVG
Production
with a gross margin of 23.7%, this company has a comparable cost of product (23.7%)
- Fernbrook Bio Limited
23.7% - Industry AVG
Profitability
an operating margin of 29.2% make it more profitable than the average company (9%)
- Fernbrook Bio Limited
9% - Industry AVG
Employees
with 5 employees, this is below the industry average (35)
5 - Fernbrook Bio Limited
35 - Industry AVG
Pay Structure
on an average salary of £42k, the company has an equivalent pay structure (£42k)
- Fernbrook Bio Limited
£42k - Industry AVG
Efficiency
resulting in sales per employee of £466.6k, this is more efficient (£292.9k)
- Fernbrook Bio Limited
£292.9k - Industry AVG
Debtor Days
it gets paid by customers after 33 days, this is near the average (40 days)
- Fernbrook Bio Limited
40 days - Industry AVG
Creditor Days
its suppliers are paid after 65 days, this is slower than average (26 days)
- Fernbrook Bio Limited
26 days - Industry AVG
Stock Days
it holds stock equivalent to 8 days, this is more than average (3 days)
- Fernbrook Bio Limited
3 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 173 weeks, this is more cash available to meet short term requirements (21 weeks)
173 weeks - Fernbrook Bio Limited
21 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 72.7%, this is a similar level of debt than the average (69%)
72.7% - Fernbrook Bio Limited
69% - Industry AVG
FERNBROOK BIO LIMITED financials
Fernbrook Bio Limited's latest turnover from December 2023 is estimated at £2.3 million and the company has net assets of £3.9 million. According to their latest financial statements, Fernbrook Bio Limited has 5 employees and maintains cash reserves of £4.4 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2023 | Dec 2022 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | Jan 2017 | Jul 2015 | Jul 2014 | Jul 2013 | Jul 2012 | Jul 2011 | Jul 2010 | Jul 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 2,358,484 | 2,188,893 | 2,151,269 | 1,752,846 | 1,842,646 | 1,333,998 | 2,626,618 | 2,185,214 | |||||||
Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||
Cost Of Sales | 1,459,466 | 1,347,864 | 1,093,584 | 877,142 | 976,753 | 726,622 | 1,080,345 | 1,229,251 | |||||||
Gross Profit | 899,018 | 841,029 | 1,057,685 | 875,704 | 865,893 | 607,376 | 1,546,273 | 955,963 | |||||||
Admin Expenses | 1,693,428 | 1,675,654 | 1,430,485 | 1,463,857 | 999,833 | 383,809 | 1,583,336 | 484,033 | |||||||
Operating Profit | -794,410 | -834,625 | -372,800 | -588,153 | -133,940 | 223,567 | -37,063 | 471,930 | |||||||
Interest Payable | 349,450 | 255,005 | 249,157 | 266,129 | 274,954 | 277,633 | 248,565 | 110,386 | |||||||
Interest Receivable | 0 | 0 | 83 | 0 | 0 | 0 | 16 | 0 | |||||||
Pre-Tax Profit | -1,143,860 | -546,217 | -621,874 | -854,282 | -408,894 | -54,066 | -285,612 | 361,544 | |||||||
Tax | 0 | -301,000 | -12,000 | 54,861 | 24,000 | 10,708 | 109,067 | -83,191 | |||||||
Profit After Tax | -1,143,860 | -847,217 | -633,874 | -799,421 | -384,894 | -43,358 | -176,545 | 278,353 | |||||||
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 250,000 | 0 | |||||||
Retained Profit | -1,143,860 | -847,217 | -633,874 | -799,421 | -384,894 | -43,358 | -426,545 | 278,353 | |||||||
Employee Costs | 209,007 | 302,003 | 169,915 | 144,413 | 122,978 | 116,829 | 235,467 | 185,794 | |||||||
Number Of Employees | 5 | 5 | 7 | 7 | 6 | 6 | 6 | 8 | 8 | ||||||
EBITDA* | -401,668 | -441,408 | 108,082 | -71,185 | 340,607 | 701,823 | 671,607 | 901,383 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023 | Dec 2022 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | Jan 2017 | Jul 2015 | Jul 2014 | Jul 2013 | Jul 2012 | Jul 2011 | Jul 2010 | Jul 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 8,676,166 | 3,062,666 | 3,125,471 | 3,213,385 | 3,445,267 | 3,820,534 | 3,916,557 | 4,208,698 | 4,555,826 | 4,934,530 | 4,973,790 | 4,878,808 | 3,908,590 | 1,267,672 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48,865 | 75,512 | 0 | 0 |
Total Fixed Assets | 8,676,166 | 3,062,666 | 3,125,471 | 3,213,385 | 3,445,267 | 3,820,534 | 3,916,557 | 4,208,698 | 4,555,826 | 4,934,530 | 4,973,790 | 4,927,673 | 3,984,102 | 1,267,672 | 0 |
Stock & work in progress | 41,406 | 40,098 | 34,211 | 31,808 | 21,441 | 20,267 | 6,557 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Debtors | 215,539 | 43,139 | 96,005 | 56,123 | 28,856 | 228,634 | 126,316 | 182,425 | 406,349 | 748,817 | 423,656 | 498,830 | 226,838 | 1,362,812 | 0 |
Group Debtors | 0 | 0 | 0 | 24,743 | 16,277 | 2,033 | 19,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 777,601 | 687,849 | 315,078 | 196,922 | 247,393 | 370,193 | 627,220 | 263,282 | 368,615 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 4,448,423 | 494,562 | 1,650,334 | 206,274 | 127,322 | 462,886 | 416,087 | 628,410 | 442,285 | 380,164 | 466,320 | 21,081 | 23,145 | 3,542 | 0 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 5,482,969 | 1,265,648 | 2,095,628 | 515,870 | 441,289 | 1,084,013 | 1,195,180 | 1,074,117 | 1,217,249 | 1,128,981 | 889,976 | 519,911 | 249,983 | 1,366,354 | 0 |
total assets | 14,159,135 | 4,328,314 | 5,221,099 | 3,729,255 | 3,886,556 | 4,904,547 | 5,111,737 | 5,282,815 | 5,773,075 | 6,063,511 | 5,863,766 | 5,447,584 | 4,234,085 | 2,634,026 | 0 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 173,723 | 162,004 | 60,271 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 266,569 | 240,547 | 233,704 | 226,861 | 220,018 | 280,724 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 319,717 | 264,263 | 349,661 | 213,523 | 65,729 | 163,819 | 67,213 | 240,168 | 68,535 | 1,306,825 | 1,507,644 | 1,516,139 | 1,175,785 | 2,637,811 | 0 |
Group/Directors Accounts | 0 | 396,533 | 47,082 | 1,522,519 | 1,005,230 | 651,008 | 290,524 | 215,211 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 65,387 | 61,301 | 63,271 | 75,187 | 33,688 | 51,962 | 0 | 155,650 | 163,358 | 159,194 | 0 | 0 |
other current liabilities | 1,011,996 | 213,899 | 226,877 | 193,093 | 140,621 | 213,193 | 123,402 | 143,689 | 2,362,483 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 1,331,713 | 874,695 | 623,620 | 2,261,091 | 1,513,428 | 1,324,995 | 783,187 | 852,774 | 2,763,704 | 1,306,825 | 1,837,017 | 1,841,501 | 1,395,250 | 2,637,811 | 0 |
loans | 8,957,676 | 5,455,494 | 5,455,494 | 2,664,729 | 2,887,568 | 3,193,270 | 3,485,103 | 3,689,670 | 1,654,183 | 0 | 1,393,994 | 1,570,244 | 595,877 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 10,232 | 70,483 | 131,784 | 195,055 | 30,753 | 80,425 | 0 | 180,582 | 339,397 | 502,683 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3,825,056 | 1,813,000 | 1,955,000 | 2,000,000 | 0 | 0 |
provisions | 0 | 0 | 0 | 301,000 | 289,000 | 329,000 | 338,000 | 355,868 | 494,468 | 429,688 | 364,698 | 0 | 0 | 0 | 0 |
total long term liabilities | 8,957,676 | 5,455,494 | 5,455,494 | 2,975,961 | 3,247,051 | 3,654,054 | 4,018,158 | 4,076,291 | 2,229,076 | 4,254,744 | 3,752,274 | 3,864,641 | 3,098,560 | 0 | 0 |
total liabilities | 10,289,389 | 6,330,189 | 6,079,114 | 5,237,052 | 4,760,479 | 4,979,049 | 4,801,345 | 4,929,065 | 4,992,780 | 5,561,569 | 5,589,291 | 5,706,142 | 4,493,810 | 2,637,811 | 0 |
net assets | 3,869,746 | -2,001,875 | -858,015 | -1,507,797 | -873,923 | -74,502 | 310,392 | 353,750 | 780,295 | 501,942 | 274,475 | -258,558 | -259,725 | -3,785 | 0 |
total shareholders funds | 3,869,746 | -2,001,875 | -858,015 | -1,507,797 | -873,923 | -74,502 | 310,392 | 353,750 | 780,295 | 501,942 | 274,475 | -258,558 | -259,725 | -3,785 | 0 |
Dec 2023 | Dec 2022 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | Jan 2017 | Jul 2015 | Jul 2014 | Jul 2013 | Jul 2012 | Jul 2011 | Jul 2010 | Jul 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | -794,410 | -834,625 | -372,800 | -588,153 | -133,940 | 223,567 | -37,063 | 471,930 | |||||||
Depreciation | 271,923 | 392,742 | 393,217 | 480,882 | 516,968 | 474,547 | 478,256 | 708,670 | 429,453 | 415,334 | 367,286 | 289,017 | 150,978 | 0 | |
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Tax | 0 | -301,000 | -12,000 | 54,861 | 24,000 | 10,708 | 109,067 | -83,191 | |||||||
Stock | 1,308 | 8,290 | 2,403 | 10,367 | 1,174 | 13,710 | 6,557 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors | 262,152 | 453,200 | 133,295 | -14,738 | -308,334 | -171,676 | 326,829 | 445,707 | 26,147 | 325,161 | -124,039 | 245,345 | -1,060,462 | 1,362,812 | 0 |
Creditors | 55,454 | 50,740 | 136,138 | 147,794 | -98,090 | 96,606 | -172,955 | 240,168 | -1,238,290 | -200,819 | -8,495 | 340,354 | -1,462,026 | 2,637,811 | 0 |
Accruals and Deferred Income | 798,097 | 20,806 | 33,784 | 52,472 | -72,572 | 89,791 | -20,287 | 143,689 | 2,362,483 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 0 | -301,000 | -301,000 | 12,000 | -40,000 | -9,000 | -17,868 | 355,868 | 64,780 | 64,990 | 364,698 | 0 | 0 | 0 | 0 |
Cash flow from operations | -1,092,612 | -1,009,184 | 312,719 | 80,174 | 699,970 | 168,035 | 1,074,692 | 1,981,018 | |||||||
Investing Activities | |||||||||||||||
capital expenditure | 0 | 0 | |||||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | 0 | 0 | |||||||||||||
Financing Activities | |||||||||||||||
Bank loans | 0 | -266,569 | -266,569 | 26,022 | 6,843 | 6,843 | 6,843 | 220,018 | 280,724 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | -396,533 | -1,125,986 | -1,475,437 | 517,289 | 354,222 | 360,484 | 75,313 | 215,211 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 3,502,182 | 2,790,765 | 2,790,765 | -222,839 | -305,702 | -291,833 | -204,567 | 3,689,670 | 1,654,183 | -1,393,994 | -176,250 | 974,367 | 595,877 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | -75,619 | -75,619 | -56,165 | -63,271 | -75,187 | 205,801 | 64,441 | 132,387 | -336,232 | -166,523 | -159,122 | 661,877 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3,825,056 | 2,012,056 | -142,000 | -45,000 | 2,000,000 | 0 | 0 |
share issue | |||||||||||||||
interest | -349,450 | -255,005 | -249,074 | -266,129 | -274,954 | -277,633 | -248,549 | -110,386 | |||||||
cash flow from financing | 1,622,923 | 2,215,134 | 15,233 | -274,037 | -274,647 | -194,243 | 4,721,086 | -1,868,148 | |||||||
cash and cash equivalents | |||||||||||||||
cash | 3,953,861 | 288,288 | 1,444,060 | 78,952 | -335,564 | 46,799 | -212,323 | 628,410 | 62,121 | -86,156 | 445,239 | -2,064 | 19,603 | 3,542 | 0 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -173,723 | 11,719 | 101,733 | 60,271 | 0 | 0 |
change in cash | 3,953,861 | 288,288 | 1,444,060 | 78,952 | -335,564 | 46,799 | -212,323 | 628,410 | 62,121 | 87,567 | 433,520 | -103,797 | -40,668 | 3,542 | 0 |
fernbrook bio limited Credit Report and Business Information
Fernbrook Bio Limited Competitor Analysis
Perform a competitor analysis for fernbrook bio limited by selecting its closest rivals, whether from the WATER SUPPLY; SEWERAGE, WASTE MANAGEMENT AND REMEDIATION ACTIVITIES sector, other small companies, companies in NN16 area or any other competitors across 12 key performance metrics.
fernbrook bio limited Ownership
FERNBROOK BIO LIMITED group structure
Fernbrook Bio Limited has no subsidiary companies.
Ultimate parent company
GENERATE EUROPE HOLDINGS LLC
#0148255
2 parents
FERNBROOK BIO LIMITED
06595831
fernbrook bio limited directors
Fernbrook Bio Limited currently has 4 directors. The longest serving directors include Mr Jamie Williams (Dec 2021) and Mr Charles Sheldon (Dec 2021).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Jamie Williams | England | 46 years | Dec 2021 | - | Director |
Mr Charles Sheldon | United Kingdom | 39 years | Dec 2021 | - | Director |
Mr Stuart Baugh | England | 33 years | Mar 2023 | - | Director |
Mr Daniel Meccariello | England | 38 years | Mar 2023 | - | Director |
P&L
December 2023turnover
2.3m
-1%
operating profit
680k
0%
gross margin
23.8%
-37.75%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
3.9m
-2.93%
total assets
14.2m
+2.27%
cash
4.4m
+7.99%
net assets
Total assets minus all liabilities
fernbrook bio limited company details
company number
06595831
Type
Private limited with Share Capital
industry
38210 - Treatment and disposal of non-hazardous waste
incorporation date
May 2008
age
16
incorporated
UK
ultimate parent company
accounts
Small Company
last accounts submitted
December 2023
previous names
seckloe 397 limited (July 2008)
accountant
JBC ACCOUNTANTS LIMITED
auditor
-
address
fernbrook bio rothwell road, kettering, NN16 8XF
Bank
HSBC BANK PLC
Legal Advisor
-
fernbrook bio limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 4 charges/mortgages relating to fernbrook bio limited. Currently there are 0 open charges and 4 have been satisfied in the past.
fernbrook bio limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for FERNBROOK BIO LIMITED. This can take several minutes, an email will notify you when this has completed.
fernbrook bio limited Companies House Filings - See Documents
date | description | view/download |
---|